SCHEMBL21844837

SCHEMBL21844837

O=C(Nc1cc(F)cc(F)c1)c1cccc(CCN2CCC(O)CC2)c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 4/20 0.47
▸ HTR2C P28335 2/20 0.47
▸ HTR7 P34969 2/20 0.47
▸ HTR6 P50406 2/20 0.47
▸ HTR1A P08908 2/20 0.47
▸ HTR1D P28221 2/20 0.47
▸ HTR1B P28222 2/20 0.47
▸ ACKR3 P25106 3/20 0.46
▸ OPRM1 P35372 1/20 0.45
▸ UBE2M P61081 1/20 0.45
▸ DCUN1D1 Q96GG9 1/20 0.45
▸ DRD4 P21917 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ SLC6A3 Q01959 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21844944 0.93 HTR1A (0.54) HTR2AHTR2CHTR7HTR6HTR1A
SCHEMBL20083978 0.88 ACKR3 (0.43) HTR2AHTR2CHTR7HTR6HTR1A
SCHEMBL19157902 0.85 RORC (0.51) HTR2AHTR2CHTR7HTR6HTR1A
SCHEMBL21844836 0.85 ACKR3 (0.51) HTR2AHTR2CHTR7HTR6HTR1A
SCHEMBL21844945 0.84 ACKR3 (0.53) ACKR3UBE2MDCUN1D1NPC1ALDH1A1
SCHEMBL21844943 0.84 ALDH1A1 (0.54) HTR2AHTR2CHTR7HTR1AHTR1D
SCHEMBL20083898 0.84 KDR (0.44) HTR2AHTR2CHTR7HTR6HTR1A
SCHEMBL19156951 0.81 NPC1 (0.52) HTR1AHTR1DHTR1BACKR3NPC1
SCHEMBL19157408 0.81 MEN1 (0.51) HTR2AHTR2CHTR7HTR6HTR1A
SCHEMBL21844832 0.81 ACKR3 (0.50) HTR2AHTR1AHTR1DHTR1BACKR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312160-B1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS INC (US) 2020-03-18 — — EP disclosed
Send feedback